This is a demo store. No orders will be fulfilled.

Z-WEHD-FMK - ≥98.0%, high purity , CAS No.210345-00-9

    Grade & Purity:
  • ≥98%
In stock
Item Number
Z646640
Grouped product items
SKU Size
Availability
Price Qty
Z646640-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$450.90
Z646640-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$650.90
Z646640-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,950.90

Basic Description

Synonyms benzyloxycarbonyl-Trp-Glu(OMe)-His-Asp(OMe)-fluoromethylketone | HY-P0111 | Caspase-1/ICE Inhibitor Z-WEHD-FMK | Z-WEHD-FMK | L-Histidinamide, N-[(phenylmethoxy)carbonyl]-L-tryptophyl-L- | DTXSID80648727 | methyl (4S)-5-[[(2S)-1-[[(3S)-5-fluoro-1-methoxy-
Specifications & Purity ≥98%
Biochemical and Physiological Mechanisms Z-WEHD-FMK is a potent, cell-permeable and irreversible caspase-1/5 inhibitor. Z-WEHD-FMK also exhibits a robust inhibitory effect on cathepsin B activity ( IC 50 =6 μM). Z-WEHD-FMK can be used to investigate cells for evidence of apoptosis.
Storage Temp Desiccated,Store at -80°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Product Description

Z-WEHD-FMK is a potent, cell-permeable and irreversible caspase-1/5 inhibitor. Z-WEHD-FMK also exhibits a robust inhibitory effect on cathepsin B activity ( IC 50 =6 μM). Z-WEHD-FMK can be used to investigate cells for evidence of apoptosis.

In Vitro

Z-WEHD-FMK (80 μM; 9 hours) elicits a near-complete blockage of C. trachomatis -induced cleavage of golgin-84 and increases GM130 expression in cells. Z-WEHD-FMK (30 min before being exposed to E. piscicida ) effectively inhibits 0909I E. piscicida induced ZF4 cells cytotoxicity and pyroptotic morphology. And in addition, it also inhibits the cytotoxicity induced by cytosolic LPS delivery. Z-WEHD-FMK (20 μM;18-24 hours following Cr 3+ ,Ni 2+ , and Co 2+ ) significantly induces a decrease of 76% to 86% in IL-1β release with 200 to 400 ppm Cr 3+ , it also induces a decrease of 35% to 45% with 48 ppm Ni 2+ or higher, Finally, this caspase-1 inhibitor induced a decrease with 6 ppm Co 2+ , down to a level below the detection threshold, and a decrease of 40% to 48% with 12 to 24 ppm Co 2+ in bone marrow-derived macrophages (BMDM). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: C. trachomatis - or mock-infected HeLa cells Concentration: 80 μM Incubation Time: 9 hours Result: Increased golgin-84 and GM130 expression. Cell Viability AssayCell Line: Mycoplasma free-ZF4 cells Concentration: Incubation Time: 30 min before being exposed to E. piscicida Result: Inhibited ZF4 cells cytotoxicity and pyroptotic morphology.

Form:Solid

IC50& Target:Cathepsin B|Caspase-1

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Organic acids and derivatives
Class Peptidomimetics
Subclass Hybrid peptides
Intermediate Tree Nodes Not available
Direct Parent Hybrid peptides
Alternative Parents Histidine and derivatives  Glutamic acid and derivatives  N-acyl-alpha amino acids and derivatives  Tryptamines and derivatives  Alpha amino acid amides  Beta amino acids and derivatives  Benzyloxycarbonyls  3-alkylindoles  Gamma-keto acids and derivatives  Imidazolyl carboxylic acids and derivatives  Fatty acid methyl esters  N-acyl amines  Substituted pyrroles  Dicarboxylic acids and derivatives  Methyl esters  Alpha-haloketones  Carbamate esters  Heteroaromatic compounds  Organic carbonic acids and derivatives  Secondary carboxylic acid amides  Azacyclic compounds  Hydrocarbon derivatives  Alkyl fluorides  Organic oxides  Organopnictogen compounds  Organofluorides  Organonitrogen compounds  
Molecular Framework Aromatic heteropolycyclic compounds
Substituents Hybrid peptide - Histidine or derivatives - Glutamic acid or derivatives - N-acyl-alpha amino acid or derivatives - Alpha-amino acid amide - Triptan - Beta amino acid or derivatives - N-substituted-alpha-amino acid - Alpha-amino acid or derivatives - Benzyloxycarbonyl - 3-alkylindole - Indole - Indole or derivatives - Gamma-keto acid - Imidazolyl carboxylic acid derivative - Fatty acid ester - Fatty acid methyl ester - Dicarboxylic acid or derivatives - Fatty amide - Benzenoid - Keto acid - N-acyl-amine - Monocyclic benzene moiety - Fatty acyl - Substituted pyrrole - Carbamic acid ester - Methyl ester - Alpha-haloketone - Azole - Imidazole - Pyrrole - Heteroaromatic compound - Carbonic acid derivative - Carboxamide group - Ketone - Carboxylic acid ester - Secondary carboxylic acid amide - Organoheterocyclic compound - Carboxylic acid derivative - Azacycle - Hydrocarbon derivative - Organic oxygen compound - Organopnictogen compound - Carbonyl group - Organic nitrogen compound - Organohalogen compound - Organofluoride - Organonitrogen compound - Alkyl halide - Organooxygen compound - Organic oxide - Alkyl fluoride - Aromatic heteropolycyclic compound
Description This compound belongs to the class of organic compounds known as hybrid peptides. These are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond.
External Descriptors Not available

Names and Identifiers

IUPAC Name methyl (4S)-5-[[(2S)-1-[[(3S)-5-fluoro-1-methoxy-1,4-dioxopentan-3-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-[[(2S)-3-(1H-indol-3-yl)-2-(phenylmethoxycarbonylamino)propanoyl]amino]-5-oxopentanoate
INCHI InChI=1S/C37H42FN7O10/c1-53-32(47)13-12-27(34(49)44-30(15-24-19-39-21-41-24)36(51)43-28(31(46)17-38)16-33(48)54-2)42-35(50)29(14-23-18-40-26-11-7-6-10-25(23)26)45-37(52)55-20-22-8-4-3-5-9-22/h3-11,18-19,21,27-30,40H,12-17,20H2,1-2H3,(H,39,41)(H,42,50)(H,43,51)(H,44,49)(H,45,52)/t27-,28-,29-,30-/m0/s1
InChIKey NLZNSSWGRVBWIX-KRCBVYEFSA-N
Smiles COC(=O)CCC(C(=O)NC(CC1=CN=CN1)C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)OCC4=CC=CC=C4
Isomeric SMILES COC(=O)CC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)OC)C(=O)CF)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)OCC4=CC=CC=C4
Alternate CAS 210345-00-9
PubChem CID 25108687
Molecular Weight 763.77

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Chemical and Physical Properties

Solubility DMSO : 100 mg/mL (130.93 mM; Need ultrasonic)
Molecular Weight 763.800 g/mol
XLogP3 2.000
Hydrogen Bond Donor Count 6
Hydrogen Bond Acceptor Count 12
Rotatable Bond Count 23
Exact Mass 763.298 Da
Monoisotopic Mass 763.298 Da
Topological Polar Surface Area 240.000 Ų
Heavy Atom Count 55
Formal Charge 0
Complexity 1330.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 4
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 1

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.